Coverage
-
January 11, 2024
A Louisiana federal judge has revoked the right of a woman alleging Novo Nordisk Inc. failed to warn about certain side effects of diabetes drug Ozempic to amend her breach of express warranty claim, saying her 30-day window to bolster her case has passed.
4 other articles on this case.
View all »